MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
about
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasionMicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsNF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageSignificance of miR-196b in tumor-related epilepsy of patients with gliomas.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyMiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic valueComparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumourPrognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1RSpecific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma.Novel classes of non-coding RNAs and cancerMicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patientsRole of MicroRNAs in Malignant GliomaInhibition of miR-21 in glioma cells using catalytic nucleic acidsEpigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.Emerging biomarkers in glioblastomaThe prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme.MicroRNAs in cancer diagnosis and therapy: from bench to bedside.MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.Current progress for the use of miRNAs in glioblastoma treatment.MicroRNA biomarkers in glioblastoma.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.Molecular prognostic factors in glioblastoma: state of the art and future challenges.Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.Prognostic Role of microRNA-21 Expression in Brain Tumors: a Meta-analysis.microRNA therapies in cancer.
P2860
Q24633772-EB6BEE2D-6179-4E44-9A09-8F8F12580976Q26747273-CD17F09D-33B9-416B-A3EE-28C2A4AE0971Q26830388-627D04CA-97C8-4099-A0C3-C32D3D9FBD52Q31104534-C4E0F2F7-97D0-4FBB-9770-DCC6DBABC9DCQ33911224-2FF83381-E365-4AAF-B863-38D470BE7AC5Q34313824-2CC4DF60-2576-4200-B8B6-348AE729C1AEQ34409620-E3776D56-F411-4C74-B572-8E1EDC88E913Q34436424-88634216-DFCF-4C0A-8D55-0937F8424678Q34450679-A55428B6-125C-4AAC-89B6-91E5CFB7DDBAQ34478948-D55A1FDB-3B19-4608-941A-1ABFAB394B1EQ34826310-F52160EE-5CBC-4F86-859B-1B9C4AD3E3FFQ34991208-52A68AE2-52AC-43BA-8963-421544A56FB7Q35163343-265D2DE9-198C-4466-8B65-DE72C302408FQ35376154-20B6984E-516F-4956-8EE7-C42977575E52Q35632595-414956A1-8346-4BC8-BD58-6CE7AA8F4957Q35857777-5911B96D-5C79-44AF-A281-8872A182DD4CQ35959917-FE61BA21-437A-48A1-AD73-8680BC5479A5Q36112656-3E5A2967-BCC3-497B-9E54-B3D69D5B098EQ36209417-D5250021-3E0B-4EC9-98C2-8269ED9FB7ECQ36480448-331FD25A-D676-4BA3-B455-FBB34B2579F1Q36540471-BEF1EBA6-02D2-4CDF-B868-67354619AA72Q36552755-DCD32143-D15A-4B47-9D69-C9B5C38A5473Q36797902-3E7D5420-35FB-4892-8CBE-5C8BC34A6DEEQ36799623-C539905A-D043-49DC-9E95-F8244707146BQ37030916-EB906F3D-84A9-4B52-AB24-9E7D78F66563Q37226521-15AFD543-5FFE-469E-A10D-BAD4454CF19FQ37619766-132B65B8-E5F4-4458-A31F-F837E775D55CQ37699427-25451C6B-6087-4965-8EE6-5359337FDF19Q37701707-328FFC99-30C3-4F49-8FC5-150A843AF179Q38027227-3691C08D-B433-4C7E-A298-587E114783E7Q38034755-9718E930-0C64-4C1A-AF28-01E2C78C582EQ38057979-6C2D393F-7A22-47A9-80DF-197AE76CA5D5Q38097384-1C6892C8-64F3-4FCE-826B-4474735275C6Q38102611-10AF3D84-2FD2-4F5C-97CE-8C6D5763D004Q38108768-E749C7ED-A0EE-42C8-8CBE-1EA20182CCAFQ38221290-2100D5F4-DF08-41FC-B7C7-BF79DC7EF2D6Q38233134-D0DAFB25-BC7D-4FBA-8F5D-4C2E38EC7244Q38272241-1A42ADF3-B241-4276-887A-8EBB6122C8D2Q38384219-8219D368-E774-4C91-8049-019C548FA44CQ38521725-A1F20464-B415-4A29-B4E8-6E1F9B7AA16B
P2860
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@en
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@nl
type
label
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@en
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@nl
prefLabel
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@en
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@nl
P2093
P2860
P1433
P1476
MiR-195, miR-196b, miR-181c, m ...... come in glioblastoma patients.
@en
P2093
Eva Lzicarova
Hana Dolezelova
Jaroslav Michalek
Marek Svoboda
Marian Hajduch
Martin Smrcka
Ondrej Slaby
Pavel Fadrus
P2860
P304
P356
10.1111/J.1349-7006.2011.02092.X
P577
2011-10-12T00:00:00Z